SCHEMBL97363

SCHEMBL97363

O=[C]C=CC=Cc1ccc(F)c(Cl)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.37
PKM P14618 1/20 0.37
MAPK1 P28482 1/20 0.37
KMT2A Q03164 1/20 0.37
ALDH1A1 P00352 1/20 0.36
NFE2L2 Q16236 2/20 0.36
CHAT P28329 1/20 0.36
TRPA1 O75762 1/20 0.35
SLC2A1 P11166 1/20 0.35
PYGL P06737 5/20 0.33
PTGES2 Q9H7Z7 1/20 0.33
KDM4A O75164 1/20 0.33
KDM4B O94953 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL97362 1.00 POLB (0.37) POLBPKMMAPK1KMT2AALDH1A1
SCHEMBL2360504 0.88 TRPA1 (0.38) POLBPKMMAPK1KMT2AALDH1A1
SCHEMBL2360503 0.88 TRPA1 (0.38) POLBPKMMAPK1KMT2AALDH1A1
SCHEMBL14989926 0.79 XDH (0.48) POLBPKMMAPK1KMT2AALDH1A1
SCHEMBL18345531 0.79 XDH (0.48) POLBPKMMAPK1KMT2AALDH1A1
SCHEMBL4498689 0.74 ALDH1A1 (0.54) KMT2AALDH1A1CHATPYGLKDM4A
SCHEMBL5163388 0.74 ALDH1A1 (0.54) KMT2AALDH1A1CHATPYGLKDM4A
SCHEMBL11045502 0.74 NFE2L2 (0.52) NFE2L2TRPA1
SCHEMBL11045499 0.74 NFE2L2 (0.52) NFE2L2TRPA1
SCHEMBL14990171 0.74 KCNA3 (0.39) ALDH1A1NFE2L2CHATPYGLPTGES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20090326008-A1 NF-kappa B Inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-12-31 US disclosed
EP-2043644-A1 NF- B INHIBITOR Otsuka Pharmaceutical Co., Ltd. (JP) 2009-04-08 EP disclosed
WO-2008010601-A1 NF- ϰB INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-01-24 WO disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326008-A1 NF-kappa B Inhibitor NFKBIA, NFKB2, IKBKB POLB 1340/4885PKM 3397/4885MAPK1 173/4885
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 POLB 4329/4885PKM 2789/4885MAPK1 982/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 POLB 4329/4885PKM 2789/4885MAPK1 982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.